Published in Sex Transm Dis on July 01, 1997
Surveillance systems for STIs in the European Union: facing a changing epidemiology. Sex Transm Infect (2004) 1.45
Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. Antimicrob Agents Chemother (2001) 1.05
Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999. J Clin Microbiol (2000) 0.91
Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing. J Clin Microbiol (2011) 0.90
Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis. Antimicrob Agents Chemother (1998) 3.34
VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol (2003) 2.98
Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2). Antimicrob Agents Chemother (1996) 2.74
Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium. FEMS Microbiol Lett (1998) 2.68
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother (2000) 2.62
Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece. J Antimicrob Chemother (2000) 2.29
Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother (1990) 2.20
Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin. Antimicrob Agents Chemother (1989) 2.17
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob Agents Chemother (1997) 2.05
Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J Antimicrob Chemother (2003) 1.97
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother (2007) 1.81
Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J Clin Microbiol (1999) 1.79
A plasmid-mediated beta-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia. J Antimicrob Chemother (1998) 1.79
Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase. J Antimicrob Chemother (1998) 1.75
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1. J Antimicrob Chemother (2001) 1.60
Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1. J Antimicrob Chemother (2006) 1.58
Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate. J Clin Microbiol (1999) 1.51
Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents (2003) 1.46
Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents (2004) 1.45
Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4. FEMS Microbiol Lett (1998) 1.43
Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases. J Antimicrob Chemother (1998) 1.39
Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. J Clin Microbiol (2005) 1.33
Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol Lett (1996) 1.32
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect (1995) 1.31
On the incidence of antibiotic resistance among aerobic gram-negative rods isolated in Greek hospitals. J Hosp Infect (1993) 1.28
CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid. Antimicrob Agents Chemother (2004) 1.26
Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J Clin Microbiol (2003) 1.24
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece. Clin Microbiol Infect (2004) 1.19
Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrob Agents Chemother (2005) 1.18
Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-beta-lactamase gene in Klebsiella pneumoniae. Antimicrob Agents Chemother (2010) 1.18
Epidemiologic aspects of male gonococcal infection in Greece. Sex Transm Dis (1999) 1.12
Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1. FEMS Microbiol Lett (2003) 1.10
High prevalence of stably derepressed class-I beta-lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals. J Med Microbiol (1992) 1.09
Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol (1997) 1.08
Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol (2008) 1.07
Panresistance in VIM-1-producing Klebsiella pneumoniae. J Antimicrob Chemother (2005) 1.07
Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals. Eur J Clin Microbiol Infect Dis (1994) 1.07
Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147. Antimicrob Agents Chemother (2011) 1.05
Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. Antimicrob Agents Chemother (2001) 1.05
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids. Antimicrob Agents Chemother (2008) 1.05
Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa. Eur J Epidemiol (1992) 1.03
Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill (2012) 1.01
Molecular typing of multidrug-resistant Salmonella Blockley outbreak isolates from Greece. Emerg Infect Dis (2000) 1.01
Methicillin-resistant Staphylococcus aureus in the hospitals of central Greece. Int J Antimicrob Agents (2001) 1.01
Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene. Clin Microbiol Infect (2006) 1.00
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece. J Clin Microbiol (2002) 0.98
Repeated occurrence of diverse extended-spectrum beta-lactamases in minor serotypes of food-borne Salmonella enterica subsp. enterica. J Clin Microbiol (2005) 0.96
Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation. J Antimicrob Chemother (2000) 0.95
Sequence of pR3521, an IncB plasmid from Escherichia coli encoding ACC-4, SCO-1, and TEM-1 beta-lactamases. Antimicrob Agents Chemother (2010) 0.95
Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns. Gut (1996) 0.94
CTX-m-3 beta-lactamase-producing Escherichia coli from Greece. Microb Drug Resist (2002) 0.94
Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model. Clin Microbiol Infect (2007) 0.94
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2010) 0.93
Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli. FEMS Microbiol Lett (2001) 0.93
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2. Int J Antimicrob Agents (2010) 0.92
Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase. J Antimicrob Chemother (2013) 0.92
Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999. J Clin Microbiol (2000) 0.91
Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541. Int J Antimicrob Agents (2008) 0.91
Value of oropharyngeal Mallampati classification in predicting difficult laryngoscopy among obese patients. Eur J Anaesthesiol (1998) 0.90
Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to β-lactams. Eur J Clin Microbiol Infect Dis (2011) 0.89
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli. Antimicrob Agents Chemother (2007) 0.89
Transferable DHA-1 cephalosporinase in Escherichia coli. Int J Antimicrob Agents (2005) 0.89
Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. J Antimicrob Chemother (1999) 0.88
Detecting VIM-1 production in Proteus mirabilis by an imipenem-dipicolinic acid double disk synergy test. J Clin Microbiol (2009) 0.87
Providencia stuartii with VIM-1 metallo-beta-lactamase. J Antimicrob Chemother (2007) 0.87
Characterization of pKP1433, a novel KPC-2-encoding plasmid from Klebsiella pneumoniae sequence type 340. Antimicrob Agents Chemother (2013) 0.86
Diversity of beta-lactamases among Klebsiella pneumoniae strains isolated in a university hospital in Greece. Eur J Epidemiol (1997) 0.86
Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis. Antimicrob Agents Chemother (2012) 0.85
A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br J Dermatol (1989) 0.85
High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospital. Diagn Microbiol Infect Dis (1997) 0.85
In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates. J Antimicrob Chemother (1994) 0.85
Evidence for chromosomal and plasmid location of CMY-2 cephalosporinase gene in Salmonella serotype Typhimurium. J Antimicrob Chemother (2008) 0.84
Antibiotic resistance, plasmid content and auxotypes of Neisseria gonorrhoeae in Greece. J Antimicrob Chemother (1988) 0.84
Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitals. Microb Drug Resist (1995) 0.84
Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes. FEMS Microbiol Lett (1998) 0.83
Prevalence of a plasmid-mediated type II dihydrofolate reductase gene among trimethoprim-resistant urinary pathogens in Greek hospitals. J Antimicrob Chemother (1992) 0.83
Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1). Int J Antimicrob Agents (2003) 0.83
Spread of the Streptococcus pneumoniae Taiwan19F-14 clone among children in Greece. Clin Microbiol Infect (2007) 0.83
Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers. Clin Microbiol Infect (2013) 0.82
Chemical analysis and antimicrobial activity of the resin Ladano, of its essential oil and of the isolated compounds. Planta Med (1999) 0.82
Prevalence of the type I and type II DHFR genes in trimethoprim-resistant urinary isolates of Escherichia coli from Greece. J Antimicrob Chemother (1993) 0.81
Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. Int J Antimicrob Agents (2007) 0.81
Infection by hepatitis B and C virus in female and transsexual Greek prostitutes with serological evidence of active syphilis. Int J STD AIDS (1997) 0.81
Lifetime prevalence fluctuations of chronic plaque psoriasis and other non-pustular clinical variants. J Eur Acad Dermatol Venereol (2008) 0.80
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases. J Antimicrob Chemother (1999) 0.80
Lifetime prevalence distribution of chronic discoid lupus erythematosus. J Eur Acad Dermatol Venereol (2007) 0.79
Evaluation of an anti-PBP 2a slide latex agglutination test in coagulase-negative staphylococci isolated in Greek hospitals. Diagn Microbiol Infect Dis (2002) 0.79
Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit. J Chemother (2000) 0.78
Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report. J Chemother (2000) 0.78
Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69. Antimicrob Agents Chemother (1998) 0.78
Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004. Clin Microbiol Infect (2006) 0.78
Seroprevalence of hepatitis B markers among female and transsexual sex workers in Athens, Greece. Genitourin Med (1997) 0.77
Performance of methods for detection of extended-spectrum beta-lactamases applied to clinical enterobacterial strains producing IBC-type beta-lactamases. J Clin Microbiol (2003) 0.77